Richard Kho
Amministratore Delegato presso Diagnose Early, Inc.
Profilo
Richard Kho is currently the Chief Executive Officer at Diagnose Early, Inc. He previously worked as the Chief Operating Officer & Director at Iterative Health, Inc. Dr. Kho holds an MBA from the University of Southern California and an undergraduate and doctorate degree from the University of California.
Posizioni attive di Richard Kho
| Società | Posizione | Inizio |
|---|---|---|
Diagnose Early, Inc.
 Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Amministratore Delegato | 21/11/2023 |
Precedenti posizioni note di Richard Kho
| Società | Posizione | Fine |
|---|---|---|
Iterative Health, Inc.
 Iterative Health, Inc. Packaged SoftwareTechnology Services Iterative Scopes, Inc. develops machine learning-powered diagnostic tools for prevention of colon cancer. The company wad founded by Jonathan Ng in 2017 and is headquartered in Boston, MA. | Direttore operativo | - |
Formazione di Richard Kho
| University of Southern California | Masters Business Admin |
| University of California | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Iterative Health, Inc.
Iterative Health, Inc. Packaged SoftwareTechnology Services Iterative Scopes, Inc. develops machine learning-powered diagnostic tools for prevention of colon cancer. The company wad founded by Jonathan Ng in 2017 and is headquartered in Boston, MA. | Technology Services |
Diagnose Early, Inc.
Diagnose Early, Inc. Pharmaceuticals: MajorHealth Technology Diagnose Early, Inc. is a company that specializes in non-invasive breath and biometric testing. The company is based in Newark, CA. The company has developed a proprietary breath analysis technology and an AI health data platform that allows users to collect their health data in one place. The company's breath testing technology is designed to provide non-invasive detection of toxins and other chemicals that may pose a health threat in minutes. Diagnose Early was founded by Boris Fain, Chris Wheeler, and John Cunniff. Chris Wheeler has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Richard Kho
